Can metabolomic profiling predict response to therapy?

Affiliations

¹ Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
² Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. s.p.young@bham.ac.uk.

Comment

Catherine M McGrath et al. Nat Rev Rheumatol. 2019 Mar.

. 2019 Mar;15(3):129-130.

doi: 10.1038/s41584-018-0136-z.

¹ Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
² Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. s.p.young@bham.ac.uk.

No abstract available

Comment on

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology.
Teitsma XM, Yang W, Jacobs JWG, Pethö-Schramm A, Borm MEA, Harms AC, Hankemeier T, van Laar JM, Bijlsma JWJ, Lafeber FPJG. Teitsma XM, et al. Arthritis Res Ther. 2018 Oct 15;20(1):230. doi: 10.1186/s13075-018-1729-2. Arthritis Res Ther. 2018. PMID: 30322408 Free PMC article. Clinical Trial.